鼻咽癌放疗并发分泌性中耳炎的治疗策略研究进展

何婷;孙宇;

1:华中科技大学同济医学院附属协和医院

摘要
<正>鼻咽癌(nasopharyngeal carcinoma,NPC)的全球发病率为每100 000人中1.2人,其发病高峰集中在东南亚和我国(每10万人中2.1~9.4人)([1])。常见的临床表现包括颈部淋巴结肿大、鼻衄、鼻塞、听力障碍、头痛和复视。由于肿瘤压迫或咽鼓管功能障碍(eustachian tube dysfunction,ETD),超过40%的鼻咽癌患者可能会出现分泌性中耳炎(oti-tis media with effusion,OME)。
关键词
基金项目(Foundation):
作者
何婷;孙宇;
参考文献

1 Ferlay J,Soerjomataram I,Dikshit R,et al.Cancer incidence and mortality worldwide:sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):E359-386.

2 Charusripan P,Khattiyawittayakun L.The effectiveness of myringotomy and ventilation tube insertion versus observation in post-radiation otitis media with effusion[J].Eur Arch Otorhinolaryngol,2017,274(9):3283-3290.

3 Xu YD,Ou YK,Zheng YQ,et al.The treatment for postirradiation otitis media with effusion:a study of three methods[J].Laryngoscope,2008,118(11):2040-2043.

4 Young YH.Irradiated ears in nasopharyngeal carcinoma survivors:a review[J].Laryngoscope,2019,129(3):637-642.

5 Ho AC,Chan JY,Ng RW,et al.The role of myringotomy and ventilation tube insertion in maxillary swing approach nasopharyngectomy:review of our 10-year experience[J].Laryngoscope,2013,123(2):376-380.

6 Hwang CF,Chien CY,Lin HC,et al.Laser myringotomy for otitis media with effusion in nasopharyngeal carcinoma patients[J].Otolaryngol Head Neck Surg,2005,132(6):924-927.

7 Kuo CL,Wang MC,Chu CH,et al.New therapeutic strategy for treating otitis media with effusion in postirradiated nasopharyngeal carcinoma patients[J].J Chin Med Assoc,2012,75(7):329-334.

8 Sun H,Cao C,Qiu X,et al.Efficacy of balloon dilatation of the eustachian tube in patients with refractory otitis media with effusion after radiotherapy for nasopharyngeal carcinoma[J].Am J Otolaryngol,2020,41(6):102724.

9 Ramakrishnan N,Kadambi P.The use of balloon eustachian tuboplasty in patients with eustachian tube dysfunction:a retrospective pilot usage experience[J].Indian J Otolaryngol Head Neck Surg,2020,72(3):392-394.

10 Ramakrishnan N,D'Souza R,Kadambi P.A systematic literature review of the safety and efficacy of eustachian balloon tuboplasty in patients with chronic eustachian tube dysfunction[J].Indian J Otolaryngol Head Neck Surg,2019,71(3):406-412.

11 Poe DS,Hanna BM.Balloon dilation of the cartilaginous portion of the eustachian tube:initial safety and feasibility analysis in a cadaver model[J].Am J Otolaryngol,2011,32(2):115-123.

12 Hwang SY,Kok S,Walton J.Balloon dilation for eustachian tube dysfunction:systematic review[J].J Laryngol Otol,2016,130(Suppl 4):S2-6.

13 Silvola J,Kivek?s I,Poe DS.Balloon dilation of the cartilaginous portion of the eustachian tube[J].Otolaryngol Head Neck Surg,2014,151(1):125-130.

14 Xiong H,Liang M,Zhang Z,et al.Efficacy of balloon dilation in the treatment of symptomatic Eustachian tube dysfunction:one year follow-up study[J].Am J Otolaryngol,2016,37(2):99-102.

15 McMurran AEL,Hogg GE,Gordon S,et al.Balloon eustachian tuboplasty for eustachian tube dysfunction:report of long-term outcomes in a UK population[J].J Laryngol Otol,2020,134(1):34-40.

16 张楠,彭洪,石增霞.自动咽鼓管吹张+球囊扩张术治疗鼻咽癌放疗患者分泌性中耳炎的研究[J].湖南师范大学学报(医学版),2018,15(3):78-80.

17 Wang SZ,Wang WF,Zhang HY,et al.Analysis of anatomical factors controlling the morbidity of radiation-induced otitis media with effusion[J].Radiother Oncol,2007,85(3):463-468.

18 Liang KL,Su MC,Twu CW,et al.Long-term result of management of otitis media with effusion in patients with post-irradiated nasopharyngeal carcinoma[J].Eur Arch Otorhinolaryngol,2011,268(2):213-217.

19 Fox NF,Xiao C,Sood AJ,et al.Hyperbaric oxygen therapy for the treatment of radiation-induced xerostomia:a systematic review[J].Oral Surg Oral Med Oral Pathol Oral Radiol,2015,120(1):22-28.

20 Chen J,Kong X,Mu F,et al.Hydrogen-oxygen therapy can alleviate radiotherapy-induced hearing loss in patients with nasopharyngeal cancer[J].Ann Palliat Med,2019,8(5):746-751.

本文信息

PDF(147K)

本文关键词相关文章

本文作者相关文章

何婷孙宇